Fong Cheng Pan1, Marcela Brissova. 1. aDepartment of Cell and Developmental Biology and Vanderbilt University Program in Developmental Biology bDivision of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Abstract
PURPOSE OF REVIEW: We highlight some of the major recent advances in characterizing human pancreas development and endocrine cell differentiation. RECENT FINDINGS: Extensive research efforts have helped to define crucial events in the mouse pancreas organogenesis. Information gained from these studies was used to develop human embryonic stem cell (hESC) differentiation protocols with the goal of generating functional glucose-responsive, insulin-producing human β-cells. In spite of remarkable progress in hESC differentiation, current protocols based on mouse developmental biology can produce human β-cells only in vivo. New differentiation markers and recently generated reagents may provide an unprecedented opportunity to develop a high-density expression map of human fetal pancreas and pancreatic islets that could serve as a reference point for in vitro hESC differentiation. SUMMARY: Integrating an increased knowledge of human pancreas development into hESC differentiation protocols has the potential to greatly advance our ability to generate functional insulin-producing cells for β-cell replacement therapy.
PURPOSE OF REVIEW: We highlight some of the major recent advances in characterizing human pancreas development and endocrine cell differentiation. RECENT FINDINGS: Extensive research efforts have helped to define crucial events in the mouse pancreas organogenesis. Information gained from these studies was used to develop human embryonic stem cell (hESC) differentiation protocols with the goal of generating functional glucose-responsive, insulin-producing human β-cells. In spite of remarkable progress in hESC differentiation, current protocols based on mouse developmental biology can produce human β-cells only in vivo. New differentiation markers and recently generated reagents may provide an unprecedented opportunity to develop a high-density expression map of human fetal pancreas and pancreatic islets that could serve as a reference point for in vitro hESC differentiation. SUMMARY: Integrating an increased knowledge of human pancreas development into hESC differentiation protocols has the potential to greatly advance our ability to generate functional insulin-producing cells for β-cell replacement therapy.
Authors: Evert Kroon; Laura A Martinson; Kuniko Kadoya; Anne G Bang; Olivia G Kelly; Susan Eliazer; Holly Young; Mike Richardson; Nora G Smart; Justine Cunningham; Alan D Agulnick; Kevin A D'Amour; Melissa K Carpenter; Emmanuel E Baetge Journal: Nat Biotechnol Date: 2008-02-20 Impact factor: 54.908
Authors: S A Sarkar; S Kobberup; R Wong; A D Lopez; N Quayum; T Still; A Kutchma; J N Jensen; R Gianani; G M Beattie; J Jensen; A Hayek; J C Hutton Journal: Diabetologia Date: 2007-12-18 Impact factor: 10.122
Authors: Rachel E Jennings; Andrew A Berry; Rebecca Kirkwood-Wilson; Neil A Roberts; Thomas Hearn; Rachel J Salisbury; Jennifer Blaylock; Karen Piper Hanley; Neil A Hanley Journal: Diabetes Date: 2013-04-29 Impact factor: 9.461
Authors: Luc Baeyens; Marie Lemper; Willem Staels; Sofie De Groef; Nico De Leu; Yves Heremans; Michael S German; Harry Heimberg Journal: Physiol Rev Date: 2018-07-01 Impact factor: 37.312